|By Marketwired .||
|August 22, 2014 09:38 PM EDT||
NEW YORK, NY--(Marketwired - August 22, 2014) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in EDAP TMS SA ("EDAP" or the "Company") (NASDAQ: EDAP) of the October 3, 2014 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against EDAP and certain executives.
A complaint has been filed in the United Stated District Court of the Southern District of New York on behalf of all persons who purchased EDAP securities between February 1, 2013 and July 30, 2014, inclusive (the "Class Period").
The complaint alleges that the Company and its executives violated federal securities laws with respect to its disclosures concerning its business, operations, and prospects.
Specifically, the action alleges that during the Class Period, Company made false and/or misleading statements and/or failed to disclose that: (i) EDAP exaggerated the efficacy and safety of its Ablatherm trials; (ii) the occurrence of the adverse events in its trials were understated; and (iii) as a result, the Company's statements were materially false and misleading at all relevant times.
On July 28, 2014, FDA staff report stated its concerns about EDAP's adequacy of their test trial methods. The staff report also revealed high rates of adverse events associated with the drug, which the Company had not properly disclosed. As a result of this report, EDAP was downgraded from "Outperform" to "Market Perform" at Northland Securities by equity analyst Suraj Kalia.
On this news, the price of EDAP stock declined by $1.23, or over 25%, to close at $3.65 on July 28, 2014.
On July 30, 2014, EDAP filed a Form 6-K with SEC and issued a press release on its discussion with the U.S. Food and Drug Administration ("FDA") Advisory Committee Meeting on Ablatherm. FDA's Gastroenterology and Urology Devices Panel ("GUDP") voted 3 yes, 5 no with one abstention regarding the safety of the drug, and 8 no with 1 abstention on the question of the risk/benefit ratio of the use of Ablatherm-HIFU device for treatment of prostate cancer.
Following this news, the price of EDAP stock declined by $1.50, or over 44%, to close at $1.92 on July 31, 2014.
Request more information now by clicking here: www.faruqilaw.com/EDAP. There is no cost or obligation to you.
If you invested in EDAP stock or options between February 1, 2013 and July 30, 2014 and would like to discuss your legal rights, visit www.faruqilaw.com/EDAP. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to [email protected]. Faruqi & Faruqi, LLP also encourages anyone with information regarding EDAP's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, throughout all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm's clients. To keep track of the latest securities litigation news, follow us on Twitter at www.twitter.com/MergerActivity or on Facebook at www.facebook.com/FaruqiLaw.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
FARUQI & FARUQI, LLP
369 Lexington Avenue, 10th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
Telephone: (877) 247-4292
Feb. 13, 2016 10:00 AM EST
Feb. 13, 2016 09:45 AM EST Reads: 226
Feb. 13, 2016 09:30 AM EST
Feb. 13, 2016 09:30 AM EST
Feb. 13, 2016 09:00 AM EST Reads: 340
Feb. 13, 2016 09:00 AM EST Reads: 241
Feb. 13, 2016 08:00 AM EST
Feb. 13, 2016 07:30 AM EST
Feb. 13, 2016 06:45 AM EST Reads: 418
Feb. 13, 2016 05:00 AM EST
Feb. 13, 2016 04:45 AM EST Reads: 466
The cloud promises new levels of agility and cost-savings for Big Data, data warehousing and analytics. But it’s challenging to understand all the options – from IaaS and PaaS to newer services like HaaS (Hadoop as a Service) and BDaaS (Big Data as a Service). In her session at @BigDataExpo at @ThingsExpo, Hannah Smalltree, a director at Cazena, will provide an educational overview of emerging “as-a-service” options for Big Data in the cloud. This is critical background for IT and data profes...
Feb. 13, 2016 03:45 AM EST Reads: 246
Father business cycles and digital consumers are forcing enterprises to respond faster to customer needs and competitive demands. Successful integration of DevOps and Agile development will be key for business success in today’s digital economy. In his session at DevOps Summit, Pradeep Prabhu, Co-Founder & CEO of Cloudmunch, covered the critical practices that enterprises should consider to seamlessly integrate Agile and DevOps processes, barriers to implementing this in the enterprise, and pr...
Feb. 13, 2016 03:00 AM EST Reads: 468
Sensors and effectors of IoT are solving problems in new ways, but small businesses have been slow to join the quantified world. They’ll need information from IoT using applications as varied as the businesses themselves. In his session at @ThingsExpo, Roger Meike, Distinguished Engineer, Director of Technology Innovation at Intuit, showed how IoT manufacturers can use open standards, public APIs and custom apps to enable the Quantified Small Business. He used a Raspberry Pi to connect sensors...
Feb. 13, 2016 02:30 AM EST Reads: 380
The principles behind DevOps are not new - for decades people have been automating system administration and decreasing the time to deploy apps and perform other management tasks. However, only recently did we see the tools and the will necessary to share the benefits and power of automation with a wider circle of people. In his session at DevOps Summit, Bernard Sanders, Chief Technology Officer at CloudBolt Software, explored the latest tools including Puppet, Chef, Docker, and CMPs needed to...
Feb. 13, 2016 02:30 AM EST Reads: 371